Li Tianquan: an in-depth analysis of the trend and progress of the consistency evaluation of generic drugs

Li Tianquan has been engaged in the research and development of the pharmaceutical industry for a long time He has undertaken a number of national and provincial research and development projects, obtained 5 national invention patents, served as the director of new drug research and development for many years, and successfully developed dozens of new products In recent years, Li Tianquan has been absorbed in the construction and utilization of medical database, and jointly established a professional China's leading medical big data service platform, yaozhi.com He is proficient in the retrieval and utilization of medical information, is good at interpreting industry policies and medical hot spots through professional data mining, in-depth analysis of the development status and trend of the pharmaceutical industry, and helps enterprises make decisions Since the new policy of conformity evaluation of generic drugs was introduced in 2016, the pharmaceutical intelligence team has jointly created the database of orange peel book of China (with freehand pharmaceutical intelligence Edition), which is widely respected and recognized by the industry Li Tianquan wrote many original articles about the consistency evaluation of generic drugs, providing suggestions for enterprises to promote the consistency evaluation of generic drugs From September 9 to 10, 2017, under the guidance of China Pharmaceutical University, Chongqing Economic and Information Technology Commission, China Pharmaceutical Education Association, and sponsored by pharma.com and China Pharmacy magazine, 2017 China Pharmaceutical Industry Summit Forum and top 100 list of R & D strength of pharmaceutical enterprises were held in Chongqing Mr Li Tianquan wrote "in-depth analysis of the trend and progress of generic drug consistency evaluation" 》Now we will share ppt of the speech as follows: